Alzheimer's disease Follow-Up Study - ALSOVA

From monitoring care, use of health and social services and costs to the prediction of resources needed in care and the importance of Alzheimer's disease from the point of view of health economy.

The members of the ALSOVA-research group, led by professor Anne Koivisto, and the coll...

Anette Hall

University Researcher, Clinical Research Centre (Canthia): Neurology

Annakaisa Haapasalo Group (Molecular Neurodegeneration)

Our research focus lies in the genetic background and molecular mechanisms underpinning neurodegenerative diseases, especially frontotemporal dementia (FTD). To this end, we utilize a variety of in vitro and in vivo model systems and patient-derived cells, clinical samples and data. We are especi...

Biomarkers for Neurodegenerative Disorders

Research focus: pathogenesis of Alzheimer's research, particularly search for new biomarkers for neurodegenerative diseases.

Biomarkers for neurodegenerative diseases are needed for early diagnosis, follow-up of the progression of the disease and monitoring of therapeutic responses...

Clinical Alzheimer Research Program

Clinical Alzheimer Research groups have a wide expertise in clinical and population based cohorts, risk factors, neuropsychology, biomarkers, genetics, brain imaging, and clinical interventions and trials in AD and mild cognitive impairment.

Flavia Scoyni

PhD student, Early Stage Researcher, A.I. Virtanen Institute for Molecular Sciences